David J. Moliterno, MD

Vice President for Clinical Affairs, College of Medicine
Chair, Department of Internal Medicine

Practice areas

  • Cardiovascular Medicine

Practice areas

  • Cardiovascular Medicine

Clinical interests

  • Cardiovascular Disease
  • Coronary Interventions
  • Hypercoagulable Syndrome
  • Interventional Cardiology
  • Ischemic Heart Disease

David J. Moliterno, MD

Vice President for Clinical Affairs, College of Medicine
Chair, Department of Internal Medicine

Biography

My name is David Moliterno; I received my medical degree from the Medical College of Virginia, Richmond. I completed a fellowship at the University of Texas Southwestern Medical Center, Dallas.

I am board certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology.

Faculty rank

Professor of Medicine

Education

Degree
Medical College of Virginia, Richmond

Residency
Vanderbilt University Medical Center, Nashville, Tenn.

Fellowship
University of Texas Southwestern Medical Center, Dallas

Certifications or Special training
American Board of Internal Medicine, Interventional Cardiology 
American Board of Internal Medicine, Cardiovascular Disease

Cardiovascular Medicine

UK Albert B. Chandler Hospital - Pavilion G
Gill Heart Institute
First Floor
1000 S. Limestone
Lexington KY 40536-0602


UK HealthCare accepts many forms of insurance. See list of insurers »

 

Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Baber U, Dangas G, Chandrasekhar J, Sartori S, Steg PG, Cohen DJ, Giustino G, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, Weisz G, Colombo A, Pocock S, Mehran R.
    Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.
    JACC Cardiovasc Interv. 2016 Jul 11;9(13):1349-57.
  2. Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S.
    Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
    J Am Coll Cardiol. 2016 May 17;67(19):2224-34.
  3. Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P.
    Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
    J Am Coll Cardiol. 2016 May 10;67(18):2135-44.
  4. Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ, White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW, Aylward PE, Strony J, Mahaffey KW, Gibson CM.
    Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy.
    Circ Cardiovasc Interv. 2016 May;9(5).
  5. Hess PL, Wojdyla DM, Al-Khatib SM, Lokhnygina Y, Wallentin L, Armstrong PW, Roe MT, Ohman EM, Harrington RA, Alexander JH, White HD, Van de Werf F, Piccini JP, Held C, Aylward PE, Moliterno DJ, Mahaffey KW, Tricoci P.
    Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.
    JAMA Cardiol. 2016 Apr 1;1(1):73-9.

View this provider on PubMed